p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice

Oncogene

Volumn 25, Issue 21, 2006, Pages 3023-3031

  Shank Calvo, J A ^a   Draheim, K ^a   Bhasin, M ^b,c   Kelliher, M A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

p16Ink4a; p19Arf; T cell leukemia; Tal1 scl

Indexed keywords

DNA BINDING PROTEIN; MUTANT PROTEIN; PROTEIN; PROTEIN P16INK4A; PROTEIN P19ARF; TAL1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA BINDING; GENE LOCUS; GENE LOSS; LEUKEMOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRELEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; EXONS; GENE DELETION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, P16; GLYCOPROTEINS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL, ACUTE; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; PRELEUKEMIA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; S PHASE; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P14ARF; WNT PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 33646877029     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209326     Document Type: Article

References (39)

1. Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J et al. (1997). Cancer Res 57: 832-836.
2. Baudino TA, Maclean KH, Brennan J, Parganas E, Yang C, Aslanian A et al. (2003). Mol Cell 11: 905-914.
3. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A et al. (2000). Embo J 19: 3337-3348.
4. Cayuela JM, Hebert J, Sigaux F. (1995). Blood 85: 854.
5. Cayuela JM, Madani A, Sanhes L, Stern MH, Sigaux F. (1996). Blood 87: 2180-2186.
6. Condorelli GL, Facchiano F, Valtieri M, Proietti E, Vitelli L, Lulli V et al. (1996). Cancer Res 56: 5113-5119.
7. Condorelli GL, Tocci A, Botta R, Facchiano F, Testa U, Vitelli L et al. (1997). Mol Cell Biol 17: 2954-2969.
8. Coppola JA, Cole MD. (1986). Nature 320: 760-763.
9. Drexler HG. (1998). Leukemia 12: 845-859.
10. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. (1999). Genes Dev 13: 2658-2669.
11. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al. (1992). Cell 69: 119-128.
12. Ferrando AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA et al. (2004). Blood 103: 1909-1911.
13. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. (2002). Cancer Cell 1: 75-87.
14. Gardie B, Cayuela JM, Martini S, Sigaux F. (1998). Blood 91: 1016-1020.
15. Green AR, DeLuca E, Begley CG. (1991). Embo J 10: 4153-4158.
16. Harrison CJ. (2001). Best Pract Res Clin Haematol 14: 593-607.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Science 281: 1509-1512.
18. Hebert J, Cayuela JM, Berkeley J, Sigaux F. (1994). Blood 84: 4038-4044.
19. Herblot S, Steff AM, Hugo P, Aplan PD, Hoang T. (2000). Nat Immunol 1: 138-144.
20. Iavarone A, Garg P, Lasorella A, Hsu J, Israel MA. (1994). Genes Dev 8: 1270-1284.
21. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL et al. (2004). N Engl J Med 351: 657-667.
22. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA et al. (1997). Cell 91: 649-659.
23. Kees UR, Burton PR, Lu C, Baker DL. (1997). Blood 89: 4161-4166.
24. Kelliher MA, Seldin DC, Leder P. (1996). Embo J 15: 5160-5166.
25. Lasorella A, Iavarone A, Israel MA. (1996). Mol Cell Biol 16: 2570-2578.
26. Look AT. (1997). Science 278: 1059-1064.
27. O'Neil J, Billa M, Oikemus S, Kelliher M. (2001). Oncogene 20: 3897-3905.
28. O'Neil J, Calvo J, McKenna K, Krishnamoorthy V, Aster JC, Bassing CH et al. (2005). Blood, 2005-06-2553.
29. O'Neil J, Shank J, Cusson N, Murre C, Kelliher M. (2004). Cancer Cell 5: 587-596.
30. Pagliuca A, Gallo P, De Luca P, Lania L. (2000). Cancer Res 60: 1376-1382.
31. Peverali FA, Ramqvist T, Saffrich R, Pepperkok R, Barone MV, Philipson L. (1994). Embo J 13: 4291-4301.
32. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. (1992). Proc Natl Acad Sci USA 89: 7742-7746.
33. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. (1996). Cell 85: 27-37.
34. Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ et al. (2001). Nature 413: 86-91.
35. Staal FJ, Clevers HC. (2005). Nat Rev Immunol 5: 21-30.
36. Valtieri M, Tocci A, Gabbianelli M, Luchetti L, Masella B, Vitelli L et al. (1998). Cancer Res 58: 562-569.
37. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. (2004). Science 306: 269-271.
38. Zhou M, Gu L, Yeager AM, Findley HW. (1997). Pediatr Hematol Oncol 14: 141-150.
39. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ et al. (1998). Genes Dev 12: 2424-2433.